Recon: Agilent to acquire Biovectra for $925M; China OKs Eli Lilly’s tirzepatide for weight loss
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySubmission and registrationUnited States